• トップページ
  • 診療のご案内
  • センターのご紹介
  • 当施設について
  • 診療関連部門診療科のご案内
  • 採用案内

埼玉県立がんセンター > 2012年度の論文リスト

ここから本文です。

 

掲載日:2018年3月26日

2012年度の論文リスト

各年度の論文リスト

※ボタンをクリックすると年度ごとに一覧を参照できます

2012年度の論文リスト

Individual transcriptional activity of estrogen receptors in primary breast cancer and its clinical significance.
Gohno, T., Seino, Y., Hanamura, T., Niwa, T., Matsumoto, M., Yaegashi, N., Oba, H., Kurosumi, M., Takei, H., Yamaguchi, Y., Hayashi, S.
Cancer Medicine, 1:328-337, 2012

Antitumor activity of chemoendocrine therapy in premenopausal and postmenopausal models with human breast cancer xenografts.
Kataoka M, Yamaguchi Y, Moriya Y, Sawada N, Yasuno H, Kondoh K, Evans DB, Mori K, Hayashi S.
Oncol Rep. 27: 303-310, 2012

ER-activating ability of breast cancer stromal fibroblasts is regulated independently of alteration of TP53 and PTEN tumor suppressor genes.
Suda, T., Oba, H., Takei, H., Kurosumi, M., Hayashi, S., Yamaguchi, Y.
Biochem. Biophys. Res. Commun., 428: 259-263, 2012

Dioxin suppresses benzo[a]pyrene-induced mutations and DNA adduct formation through cytochrome P450 1A1 induction and (±)-anti-benzo[a]pyrene-7,8-diol-9,10-epoxide inactivation in human hepatoma cells.
Shiizaki, K., Kawanishi, M., Yagi, T.?Mutat.
Res. - Genetic Toxicology and Environmental Mutagenesis, in press, 2012

Evidence of asymmetric cell division and centrosome inheritance in human neuroblastoma cells.
Izumi, H.,Kaneko, Y.
Proc. Natl. Acad.,Sci., 109: 18048-18053, 2012.

Higher cell stiffness indicating lower metastatic potential in B16 melanoma cell variants and in
(-)-epigallocatechin gallate-treated cells.
Watanabe, T., Kuramochi, H., Takahashi, A., Imai, K., Katsuta, N., Nakamura, T., Fujiki, H., Suganuma, M.
Cancer Res. Clin. Oncol., 138: 859-866, 2012

Human gastric cancer development with TNF-α-inducing protein secreted from Helicobacter pylori.
Suganuma, M., Watanabe, T., Yamaguchi, K., Takahashi, A., Fujiki, H.
Cancer Lett., 322: 133-138, 2012

Green tea: An effective synergist with anticancer drugs for tertiary cancer prevention,
Fujiki, H., Suganuma, M.
Cancer Lett., 324: 119-125, 2012

Challenging the effectiveness of green tea in primary and tertiary cancer prevention.
Fujiki, H., Imai, K., Nakachi, K., Shimizu, M., Moriwaki, H., Suganuma, M.
Cancer Res. Clin. Oncol., 138: 1259-1270, 2012

Estrogen receptor-α directly regulates sensitivity to paclitaxel in neoadjuvant chemotherapy for breast cancer.
Tokuda, E., Seino, Y., Arakawa, A, Saito, M., Kasumi, F., Hayashi, S., Yamaguchi, Y.
Breast Cancer Res. Treat., 133: 427-436, 2012

Different incidences of epigenetic but not genetic abnormalities between Wilms tumors in Japanese and Caucasian children.
Haruta, M., Arai, Y., Watanabe, N., Fujiwara, Y., Honda, S., Ohshima, J., Kasai, F., Nakadate, H., Horie, H., Okita, H., Hata, JI., Fukuzawa, M., Kaneko, Y.
Cancer Sci., 103: 1129-1135, 2012

Methylation of the RASSF1A promoter is predictive of poor outcome among patients with Wilms tumor.
Ohshima, J., Haruta, M., Fujiwara, Y., Watanabe, N., Arai, Y., Ariga, T., Okita, H., Koshinaga, T., Oue, T., Hinotsu, S., Nakadate, H., Horie, H., Fukuzawa, M., Kaneko, Y.
Pediatr. Blood Cancer, 59: 499-505, 2012

Japanese wild mice: a rich resource for new disease models.
Matsushima, Y. 
Exp Anim., 61時25分-33, 2012

Mouse models for atopic dermatitis developed in Japan
Yonekawa, H., Takada, T., Shitara, H., Taya, C.,Matsushima, Y., Matsuoka, K., Kikkawa, Y.
Atopic Dermatitis-Disease Etiology and Clinical Management (Esparza-Gordillo, J., ed.) pp2-38, 2012

Vocalizations in a Japanese wild-derived laboratory mouse KOR1: Development, behavioral contexts, and sound characteristics.
Nakagawa, R., Matsunaga, E., Okanoya, K., Matsushima, Y.
Acoust. Sci. & Tech., 33: 52-55, 2012

Extracellular NM23 protein as a therapeutic target for hematologic malignancies.
Okabe-Kado, J., Kasukabe ,T., Kaneko, Y.
Adv. Hematol., :879368. 2012.

ナノメカニカル解析に基づく肺がんの診断・治療・予防の開発
菅沼雅美
Smorking Science, 27: 6-7, 2012

日本産野生マウスからの遺伝子導入と新規疾患モデル
松島芳文
アニテックス 24時12分-19, 2012

マウスの発生,成長の透明骨格標本による観察
吉田治弘、松島芳文
専修自然科学紀要 43時01分-6, 2012

RNAi創薬と国内外の開発状況
福永淳一神津知子
BIO INDUSTRY, 29: 10"14, 2012

お問い合わせ

病院局 がんセンター  

郵便番号362-0806 埼玉県北足立郡伊奈町小室780番地 埼玉県立がんセンター

電話:048-722-1111

ファックス:048-722-1129

より良いウェブサイトにするためにみなさまのご意見をお聞かせください

このページの情報は役に立ちましたか?

このページの情報は見つけやすかったですか?